Sponsor of the Day:
Jerkmate
https://www.biospace.com/deals/merck-to-buy-terns-unprecedented-leukemia-drug-for-6-7b-as-keytruda-cliff-looms
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms - BioSpace
Mar 25, 2026 - Merck’s acquisition of Terns Pharmaceuticals follows other big-ticket purchases, including of Verona Pharma and Cidara Therapeutics, as the pharma prepares for...
buy terns6 7bmerckleukemiadrug
https://www.biopharmadive.com/news/merck-terns-acquire-deal-leukemia-drug/815637/
Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug | BioPharma Dive
If consummated, the deal would hand Merck a treatment that could challenge Novartis’ fast-selling Scemblix. But the low purchase premium — which one analyst...
drug biopharma divebuy terns6 7bmerckbet
https://www.statnews.com/2026/03/25/merck-terns-pharmaceuticals-leukemia-tern701/
Merck to buy Terns Pharmaceuticals in $6.7B deal
Mar 25, 2026 - The deal's centerpiece is a promising leukemia drug, which could help Merck offset the impending decline of Keytruda revenue.
buy terns6 7bmerckpharmaceuticalsdeal